Radiotherapy for pediatric low-grade glioma

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Neuro-oncology

Background:

• Radiotherapy is a standard treatment for pediatric low-grade glioma, crucial for survival and vision preservation.
• Concerns regarding radiotherapy complications have increased the use of chemotherapy and targeted therapies.
• Systemic therapies are linked to poorer progression-free survival outcomes compared to radiotherapy.

Purpose of the Study:

• To review the indications, timing, and outcomes of radiotherapy for pediatric low-grade glioma.
• To analyze clinical management strategies and controversies in treatment choices.
• To compare radiotherapy with chemotherapy and targeted therapy in pediatric low-grade glioma.

Main Methods:

• Comprehensive literature review of radiotherapy for pediatric low-grade glioma.
• Analysis of clinical management strategies and treatment controversies.
• Evaluation of outcomes associated with radiotherapy versus systemic therapies.

Main Results:

• Radiotherapy is essential for patients ineligible for complete resection due to tumor location or infiltrative nature.
• Deferring radiotherapy in favor of systemic therapies can lead to significant morbidity, including poor visual outcomes.
• Systemic therapy negatively impacts progression-free survival in patients who later receive radiotherapy; newer radiotherapy techniques aim to minimize complications.

Conclusions:

• Balancing radiotherapy benefits against side effects is key in managing pediatric low-grade glioma.
• Systemic therapies, while favored, show inferior progression-free survival and potential morbidity, necessitating careful consideration of radiotherapy.
• Further research is needed to optimize treatment strategies, especially with the rise of targeted therapies and their interactions with radiotherapy.